Literature DB >> 22997409

Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.

Teresa Ramirez1, Lisa Longato, Miroslav Dostalek, Ming Tong, Jack R Wands, Suzanne M de la Monte.   

Abstract

AIMS: Chronic alcohol abuse causes steatohepatitis with insulin resistance, which impairs hepatocellular growth, survival and metabolism. However, growing evidence supports the concept that progressive alcohol-related liver injury may be mediated by concurrent mal-signaling through other networks that promote insulin resistance, e.g. pro-inflammatory, pro-ceramide and endoplasmic reticulum (ER) stress cascades.
METHODS: Using the Long Evans rat model of chronic ethanol feeding, we characterized the histopathologic and ultrastructural features of steatohepatitis in relation to biochemical and molecular indices of tissue injury, inflammation, insulin resistance, dysregulated lipid metabolism and ER stress.
RESULTS: Chronic steatohepatitis with early chicken-wire fibrosis was associated with enlargement of mitochondria and disruption of ER structure by electron microscopy, elevated indices of lipid storage, lipid peroxidation and DNA damage, increased activation of pro-inflammatory cytokines, impaired signaling through the insulin receptor (InR), InR substrate-1, Akt, ribosomal protein S6 kinase and proline-rich Akt substrate 40 kDa, glycogen synthase kinase 3β activation and constitutive up-regulation of ceramide and ER stress-related genes. Liquid chromatography coupled with tandem mass spectrometry demonstrated altered ceramide profiles with higher levels of C14 and C18, and reduced C16 species in ethanol-exposed livers.
CONCLUSION: The histopathologic and ultrastructural abnormalities in chronic alcohol-related steatohepatitis are associated with persistent hepatic insulin resistance and pro-inflammatory cytokine activation, dysregulated lipid metabolism with altered ceramide profiles and both ER and oxidative stress. Corresponding increases in lipid peroxidation, DNA damage and protein carbonylation may have contributed to the chronicity and progression of disease. The findings herein suggest that multi-pronged therapeutic strategies may be needed for effective treatment of chronic alcoholic liver disease in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997409      PMCID: PMC3523384          DOI: 10.1093/alcalc/ags106

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  101 in total

1.  Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Edward Re; Lisa Longato; Ming Tong
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation.

Authors:  Yukiko Onishi; Miho Honda; Takehide Ogihara; Hideyuki Sakoda; Motonobu Anai; Midori Fujishiro; Hiraku Ono; Nobuhiro Shojima; Yasushi Fukushima; Kouichi Inukai; Hideki Katagiri; Masatoshi Kikuchi; Yoshitomo Oka; Tomoichiro Asano
Journal:  Biochem Biophys Res Commun       Date:  2003-04-11       Impact factor: 3.575

4.  Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.

Authors:  Ming Tong; Alexander Neusner; Lisa Longato; Margot Lawton; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 5.  The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Authors:  M Zeremski; L M Petrovic; A H Talal
Journal:  J Viral Hepat       Date:  2007-10       Impact factor: 3.728

6.  Involvement of phosphatidylinositol-3 kinase/AKT/PKCzeta/lambda pathway in the effect of palmitate on glucose-induced insulin secretion.

Authors:  Tatiane C A Nogueira; Gabriel F Anhê; Carla R O Carvalho; Rui Curi; Silvana Bordin; Angelo R Carpinelli
Journal:  Pancreas       Date:  2008-10       Impact factor: 3.327

7.  Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition.

Authors:  Martin J J Ronis; Angelica Butura; Soheila Korourian; Kartik Shankar; Pippa Simpson; Jamie Badeaux; Emanuele Albano; Magnus Ingelman-Sundberg; Thomas M Badger
Journal:  Exp Biol Med (Maywood)       Date:  2008-03

8.  Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas.

Authors:  Serap Koybasi; Can E Senkal; Kamala Sundararaj; Stefka Spassieva; Jacek Bielawski; Walid Osta; Terry A Day; James C Jiang; S Michal Jazwinski; Yusuf A Hannun; Lina M Obeid; Besim Ogretmen
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

9.  Insulin resistance in experimental alcohol-induced liver disease.

Authors:  Suzanne M de la Monte; Jong-Eun Yeon; Ming Tong; Lisa Longato; Rajeev Chaudhry; Mao-Yin Pang; Kevin Duan; Jack R Wands
Journal:  J Gastroenterol Hepatol       Date:  2008-05-26       Impact factor: 4.029

Review 10.  Free fatty acids and skeletal muscle insulin resistance.

Authors:  Edward W Kraegen; Gregory J Cooney
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

View more
  34 in total

1.  Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.

Authors:  Chiung-Kuei Huang; Tunan Yu; Suzanne M de la Monte; Jack R Wands; Zoltan Derdak; Miran Kim
Journal:  J Hepatol       Date:  2015-02-24       Impact factor: 25.083

2.  Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.

Authors:  Diana Lizarazo; Valerie Zabala; Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

3.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

4.  Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.

Authors:  Thiyagarajan Gopal; Narendra Kumar; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Edward N Harris; Geoffrey Talmon; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

Review 5.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

Review 6.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

Review 7.  Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes.

Authors:  Caroline Tao; Angelica Sifuentes; William L Holland
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-11-15       Impact factor: 4.690

8.  A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.

Authors:  Bianca Williams; Jason Correnti; Amanke Oranu; Annie Lin; Victoria Scott; Maxine Annoh; James Beck; Emma Furth; Victoria Mitchell; Can E Senkal; Lina Obeid; Rotonya M Carr
Journal:  FASEB J       Date:  2017-09-01       Impact factor: 5.191

Review 9.  Alcohol Modulation of the Postburn Hepatic Response.

Authors:  Michael M Chen; Stewart R Carter; Brenda J Curtis; Eileen B O'Halloran; Richard L Gamelli; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2017 Jan/Feb       Impact factor: 1.845

10.  Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice.

Authors:  Piotr Zabielski; Agnieszka Blachnio-Zabielska; Ian R Lanza; Srinivas Gopala; S Manjunatha; Daniel R Jakaitis; Xuan-Mai Persson; Jaime Gransee; Katherine A Klaus; Jill M Schimke; Michael D Jensen; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.